Posted inTrending News
FDA Greenlights Sobi’s Gamifant for Macrophage Activation Syndrome in Still’s Disease: A New Era in Treatment
Breakthrough FDA Approval for Gamifant in Treating MAS Associated with Still's DiseaseThe recent approval by the US FDA of Sobi's Gamifant (emapalumab-lzsg) marks a significant…